Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 09, 2019; 92 (15 Supplement) May 6, 2019

Cefepime-induced Non-convulsive Status Epilepticus (P2.5-022)

Chris Hollen, Syeda Maria Muzammil, Tammam Dayyoub
First published April 16, 2019,
Chris Hollen
1University of Oklahoma Health Sciences Center Oklahoma City OK United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Syeda Maria Muzammil
1University of Oklahoma Health Sciences Center Oklahoma City OK United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tammam Dayyoub
1University of Oklahoma Health Sciences Center Oklahoma City OK United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Cefepime-induced Non-convulsive Status Epilepticus (P2.5-022)
Chris Hollen, Syeda Maria Muzammil, Tammam Dayyoub
Neurology Apr 2019, 92 (15 Supplement) P2.5-022;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: To highlight the importance of recognizing Non-Convulsive Status Epilepticus (NCSE) as a serious complication in patients with encephalopathy while being treated with Cefepime.

Background: Cefepime is a 4th generation cephalosporin which is widely used to treat Gram-positive and Gram-negative bacterial infections and is frequently used during hospital admissions. Impaired renal function increases the risk for Cefepime-induced neurotoxicity and symptoms range from disorientation, aphasia, myoclonus, status epilepticus, to coma and death.

A 60-year-old female (with hypertensive emergency and respiratory failure requiring intubation) was transferred to the Neuroscience intensive care unit (NSICU) due refractory NCSE. She was being treated with Cefepime 2 gm three times a day for sepsis in a community hospital despite renal impairment. Due to persistent altered consciousness (Glasgow coma scale 6), she had undergone electroencephalographs (EEGs) which were suggestive of NCSE for which levetiracetam, lacosamide and fosphenytoin were sequentially started, however, cefepime was continued, patient was considered refractory to treatment and was transferred to our NSICU. Continuous EEG at the NSICU revealed 2–2.5 Hz generalized periodic discharges (GPDs) indicative of cefepime-induced NCSE. Cefepime was discontinued, all antiepileptics except Levetiracetam were held and continuous renal replacement therapy was initiated. Over the course of the next 6 hours, GPDs were noted to dissipate on continuous EEG and were replaced with diffuse background slowing and generalized rhythmic delta activity (GRDA). Mental status gradually improved over the next 3 days with more wakefulness and patient being able to follow simple 1-step commands crossing midline. Patient eventually was extubated and transferred to the neurology floor.

Design/Methods: Not applicable

Results: Not applicable

Conclusions: NCSEis an under-recognized complication of cefepime toxicity. Dose adjustment or avoidance of cefepime is of utmost importance when managing patients with end stagerenal disease. Early recognition is vital to improve outcome.

Disclosure: Dr. Hollen has nothing to disclose. Dr. Muzammil has nothing to disclose. Dr. Dayyoub has nothing to disclose.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 98 (24)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise